Valtech Cardio Ltd., a medical device company that develops solutions for mitral valve repair and replacement, said 11 patients have been treated with the company's transcatheter (transfemoral) Cardioband Annuloplasty System in three European medical centers.

PDI, Inc. and Transgenomic, Inc. announced the signing of a U.S. collaboration agreement to commercialize CardioPredict, a molecular diagnostic test developed by Transgenomic. CardioPredict is a broad-based genetic assay which identifies specific genes in patients that influence the effectiveness and safety of many commonly used cardiovascular drugs.

UC Davis Health System researchers have identified for the first time a biological pathway that is activated when blood sugar levels are abnormally high and causes irregular heartbeats, a condition known as cardiac arrhythmia that is linked with heart failure and sudden cardiac death.